2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
| Jazyk: | angličtina |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
ENDOTHELIN-RECEPTOR ANTAGONIST
Guidelines Pulmonary arterial hypertension Pulmonary hypertension Chronic thrombo-embolic pulmonary hypertension LONG-TERM OUTCOMES QUALITY-OF-LIFE Balloon pulmonary angioplasty Soluble guanylate cyclase stimulators Connective tissue disease CALCIUM-CHANNEL BLOCKERS Congenital heart disease RIGHT-VENTRICULAR DYSFUNCTION IMPROVES EXERCISE CAPACITY Endothelin receptor antagonists Lung transplantation PRESERVED EJECTION FRACTION EOSINOPHILIA-MYALGIA-SYNDROME Pulmonary endarterectomy Left heart disease Lung disease Prostacyclin receptor agonists Prostacyclin analogues AFFAIRS CLINICAL-ASSESSMENT Phosphodiesterase type 5 inhibitors CONTINUOUS INTRAVENOUS EPOPROSTENOL |
| Zdroj: | European Heart Journal. 43(38) |
| ISSN: | 0195-668X |
| DOI: | 10.1093/eurheartj/ehac237 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|